AI-generated summary
The authors report a 16-week randomized, double-blind, sham device-controlled trial at two institutions of a helmet-type low-level light therapy device for androgenetic alopecia. The experimental group showed a greater increase in hair density and hair thickness than the sham group, and no adverse events were reported. The authors conclude the treatment could be safe and effective.
- Participants
- 60
- Who or what was studied
- Adults aged 19 to 65 years with androgenetic alopecia, recruited at 2 institutions
- Wavelengths
- 655 nm
- Limits stated in the abstract
- The abstract does not describe a sample size calculation or the number of participants per group, and the conclusion that LLLT could be safe and effective is stated with tentative wording.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Introduction
Androgenetic alopecia is the most common form of hair loss in both sexes. In recent studies, low-level light therapy (LLLT) has been established as an effective treatment for alopecia. The purpose of this study was to evaluate the safety and efficacy of LLLT using a new helmet-type device for the treatment of androgenetic alopecia.
Method
A randomized, sham device-controlled, double-blind clinical trial was conducted at 2 institutions. Sixty participants diagnosed with androgenetic alopecia aged from 19 to 65 years were recruited. LLLT was performed through a helmet-type device that emitted light with a mean output power of 2.36 mW/cm at a wavelength of 655 nm. Participants were divided into 2 groups, which respectively used the experimental device and a sham device. After tattooing at the central point of the vertex, phototrichograms at that point were obtained at 0, 8, and 16 weeks. The primary endpoint of the study was the difference in the rate of change of hair density between the test group and the control group.
Results
Comparing the results at baseline and week 16, the experimental group showed an increase in hair density of 41.90 hairs/cm and an increase in hair thickness of 7.50 μm, whereas the control group showed an increase of 0.72 hairs/cm and a decrease of 15.03 μm, respectively (P < .001). No adverse events or side effects occurred.
Conclusion
LLLT showed a significant effect on increasing hair density in patients with androgenetic alopecia. LLLT could be a safe and effective treatment for androgenetic alopecia in both sexes.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 655 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Androgenetic alopecia, Sham device, Sham, Low-level laser therapy, Control group, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.